Avista Healthcare Partners, L.P.

Insider Reports History

Location
New York, NY
Signature
Avista Healthcare Partners GP, Ltd. By: /s/ Ben Silbert, Chief Administrative Officer and General Counsel
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Avista Healthcare Partners, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
RVL Pharmaceuticals plc 10%+ Owner Ordinary Shares 23,730,864 $740,403 $0.0312 08 Aug 2022 Direct
RVL Pharmaceuticals plc 10%+ Owner Ordinary Shares 1,032,995 $32,229 $0.0312 08 Aug 2022 By Avista Capital investment fund

Insider Reports Filed by Avista Healthcare Partners, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465922088025-avista-healthcare-partners-l-p-2022-08-08 RVL Pharmaceuticals plc 08 Aug 2022 1 +$12,400,000 4 10%+ Owner 09 Aug 2022, 17:18